SYS ONLINE
[PARTNER]

Distribute with Decoded across Southeast Asia.

Decoded engages with brands through the Decoded Entry Protocol — a six-stage framework covering inbound brief, mutual diligence, commercial framework, regulatory and channel preparation, and committed launch and stewardship across the six principal Southeast Asian markets.

Abstract network visualization showing ten connected nodes representing Decoded Longevity markets across Southeast Asia and Africa.
[VALUE]

Four commitments.

  1. 01

    Understand premium.

    Premium is preserved through channel discipline and dossier completeness — not asserted in copy. The firm declines work it cannot defend at premium positioning across the bloc.

  2. 02

    Six markets on a single standard.

    SG, MY, ID, TH, VN, PH — operated under one documentation regime and one regulatory cadence so a launch in one is the launch design for the others.

  3. 03

    Regulatory fluency, not regulatory tolerance.

    Notification and registration dossiers built once and maintained per market. Halal posture decided at formulation, not retrofitted at audit.

  4. 04

    Brand stewardship across the contract term.

    Channel discipline, pricing posture, and post-market obligations operated against a single internal record — published to principals on request.

[ENTRY PROTOCOL]

Six stages, named.

Every brand engagement runs the same protocol — start to finish — so both sides know where the relationship is at every point. Refusal is part of the work, and most engagements end at stage 2 with a written reason.

  1. STAGE 01

    Inbound brief

    Brand owner submits a structured brief — origin, category, certifications, target markets, current footprint, and the specific Southeast Asian thesis.

  2. STAGE 02

    First-pass review

    The firm assesses category fit, regulatory feasibility, and channel coherence against an internal rubric. Most relationships end here, with a written reason.

  3. STAGE 03

    Mutual diligence

    Under NDA: dossier review on the brand side, governance disclosure on the firm side. Either party may close the file at any point.

  4. STAGE 04

    Commercial framework

    Term sheet covering territory grants, exclusivity, regulatory ownership, marketing approval rights, and the specific quality and pharmacovigilance commitments.

  5. STAGE 05

    Regulatory and commercial preparation

    Notification dossiers filed in the agreed launch markets; channel partners briefed; first-shipment forecast and quality plan committed in writing.

  6. STAGE 06

    Launch and stewardship

    First market goes live; the firm publishes a brand record (regulatory status, channel set, post-market obligations) and operates against it across the contract term.

[MARKETS]

Six markets, one standard.

Each market has its own regulator, channel structure, and posture — but the documentation discipline Decoded applies is the same across the bloc.

Singapore

[MARKET·SG]

Regulator: Health Sciences Authority

prescriptive

direct-to-practitioner

Malaysia

[MARKET·MY]

Regulator: National Pharmaceutical Regulatory Agency (NPRA)

permissive-with-documentation

clinic-network

Indonesia

[MARKET·ID]

Regulator: BPOM (Balai Pengawas Obat dan Makanan)

narrative-required

distributor-led

Thailand

[MARKET·TH]

Regulator: Thai FDA (Food and Drug Administration, Ministry of Public Health)

prescriptive-hybrid

clinic-and-hospital

Vietnam

[MARKET·VN]

Regulator: Drug Administration of Vietnam

tightening

hospital-pharmacy

Philippines

[MARKET·PH]

Regulator: Bureau of Food and Drugs (BFAD)

narrative-required

clinic-pharmacy-retail

South Africa

[MARKET·ZA]

Regulator: South African Health Products Regulatory Authority (SAHPRA)

prescriptive

clinic-and-retail

Botswana

[MARKET·BW]

Regulator: Medicines Regulatory Authority of Botswana (MRAB)

streamlined

clinic-pharmacy

Namibia

[MARKET·NA]

Regulator: Ministry of Health & Social Services (MHSS) / Namibia Medicines Regulatory Council

streamlined

clinic-pharmacy

Zimbabwe

[MARKET·ZW]

Regulator: Medicines Control Authority of Zimbabwe (MCAZ)

permissive

distributor-led

[WHAT WE LOOK FOR]

Five criteria for a brand the firm will represent.

  • 01

    Manufacturing site holding category-appropriate certification (PIC/S GMP, ISO 22716, ISO 13485, HACCP, ISO 22000) with current third-party audits.

  • 02

    Existing footing in at least one demanding regulator (EU, US FDA, TGA, Health Canada, MFDS, PMDA) — or a credible plan to land one.

  • 03

    Pricing architecture that survives a Singapore-anchored launch into Indonesia, Thailand, and the Philippines without collapse.

  • 04

    Founding leadership that treats regulatory and pharmacovigilance commitments as first-order, not handle-later.

  • 05

    A specific Southeast Asian thesis — not 'global brand looking for distributors'.

[WHAT YOU CAN EXPECT]

Five commitments the firm makes in return.

  • 01

    A written first-pass review from the firm — including a refusal, when refusal is the honest answer.

  • 02

    Mutual NDA before any technical or commercial dossier crosses either way.

  • 03

    A term sheet that names the regulatory owner, the commercial framework, and the quality and pharmacovigilance commitments.

  • 04

    Notification dossiers filed in the agreed launch markets on the agreed timeline — or a written explanation if the timeline shifts.

  • 05

    A brand record published internally and shared on request — covering regulatory status, channel set, and post-market obligations.

// simulator

Regulatory pathway simulation.

Pick a category and the markets in scope. The firm's tool returns a deterministic per-market scaffold — what the regulator is, what posture the category sits under, and which obligations bind first.

[Markets]

// select a category and at least one market, then run.

output renders the firm's deterministic regulatory scaffold per market.

// assessment

Brand-fit assessment.

A five-question screen the firm runs internally before Stage 02. Answer in one sitting; the tool returns a heuristic fit score and the two dimensions that decide whether a brief proceeds.

Assessment01 / 05
Q01warning
Q02idle
Q03idle
Q04idle
Q05idle
[Q01 / 05]

Which practice area is the brand in?

// faq

Frequently asked.

  1. Q01

    Does Decoded work with brands at any stage, or only established names?

    Decoded engages with brands that hold category-appropriate manufacturing certification, an existing footing in at least one demanding regulator, and a pricing architecture that survives a Singapore-anchored launch into the rest of the bloc. Stage in years matters less than that posture being already in place.

  2. Q02

    How long does the Entry Protocol typically take from first brief to launch?

    The first-pass written review lands within fourteen working days of an inbound brief. Mutual diligence and the term sheet typically run six to ten weeks. Regulatory and channel preparation runs in parallel with notification dossier work; the timeline is decided per market and is named in the term sheet, not implied.

  3. Q03

    Across which markets does Decoded operate?

    Singapore, Malaysia, Indonesia, Thailand, Vietnam, and the Philippines — operated under one documentation regime so a launch in one market is the launch design for the others. The firm does not represent brands outside ASEAN and does not operate in markets it cannot file in.

  4. Q04

    What ends most conversations at Stage 02?

    Pricing architecture that cannot survive the bloc, missing third-party manufacturing audits, an active-ingredient profile that the firm cannot defend in front of HSA or BPOM, or a 'global brand looking for distributors' posture without a specific Southeast Asian thesis. Refusal at Stage 02 is part of the work and is delivered in writing.

  5. Q05

    Does Decoded publish pricing or commercial terms?

    No. Commercial framework, contract template, and post-market obligations are released to brand leadership under NDA via the Partner Prospectus. Pricing is not a marketing surface and is not implied by any tool output, simulator, or assessment on this site.

[STAGE 01 — INBOUND BRIEF]

Tell the firm about your brand.

A structured submission lands as Stage 01 of the Entry Protocol. The firm acknowledges every inbound brief and returns a written first-pass review — including a refusal, when refusal is the honest answer. The form interface lands in STEP 6; the inbox is live today.

Email a partner brief
[PARTNER PROSPECTUS]

The Decoded Partner Prospectus.

A working document covering the firm's mandate, regulatory posture per market, channel philosophy, and the standing contract template. Released on request to brand leadership under NDA.

Request the Prospectus